URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Michael Schell

Concepts (268)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Radiosurgery
17
1994
73
3.190
Why?
Brachytherapy
20
1985
109
2.080
Why?
Brain Neoplasms
9
1997
282
1.270
Why?
Radiotherapy Dosage
27
1979
202
0.990
Why?
Radiotherapy Planning, Computer-Assisted
10
1987
48
0.730
Why?
Central Nervous System
1
2011
117
0.730
Why?
Lung Neoplasms
7
1994
435
0.680
Why?
Radiotherapy
5
1990
198
0.610
Why?
Iodine Radioisotopes
9
1985
104
0.590
Why?
Prostatic Neoplasms
8
1985
540
0.550
Why?
Carcinoma, Squamous Cell
2
1984
238
0.500
Why?
Radiometry
5
1982
40
0.470
Why?
Dose Fractionation
6
2001
57
0.460
Why?
Stents
3
1999
132
0.410
Why?
Adenocarcinoma
1
2006
483
0.410
Why?
Fast Neutrons
8
1979
10
0.370
Why?
Humans
57
1979
37165
0.370
Why?
Beta Particles
1
1999
6
0.370
Why?
Algorithms
4
1996
543
0.360
Why?
Neutrons
5
1979
8
0.350
Why?
Coronary Vessels
2
1999
133
0.340
Why?
Blood Vessels
1
1999
93
0.330
Why?
Radiotherapy, High-Energy
6
1980
24
0.310
Why?
Ear Neoplasms
1
1996
7
0.300
Why?
Professional Staff Committees
3
2001
7
0.300
Why?
Neurilemmoma
1
1996
19
0.290
Why?
Radiation Oncology
3
2001
18
0.290
Why?
Pancreatic Neoplasms
2
1991
84
0.290
Why?
Particle Accelerators
5
1982
13
0.290
Why?
Aged, 80 and over
10
2002
2588
0.280
Why?
Vestibule, Labyrinth
1
1996
82
0.280
Why?
Pituitary Neoplasms
1
1995
66
0.260
Why?
Tunica Intima
3
1998
90
0.250
Why?
Male
29
1982
20139
0.250
Why?
Research Design
3
2001
340
0.240
Why?
Middle Aged
16
1982
10013
0.240
Why?
Brain Diseases
2
1990
134
0.230
Why?
Aged
15
1982
7392
0.230
Why?
Radiotherapy, Computer-Assisted
3
1987
15
0.220
Why?
Treatment Outcome
8
2001
2671
0.220
Why?
Feasibility Studies
4
1999
212
0.220
Why?
Stereotaxic Techniques
2
1990
33
0.210
Why?
Glioblastoma
3
1982
63
0.210
Why?
Chemoprevention
1
2011
12
0.210
Why?
Neoplasms
4
1979
743
0.200
Why?
Radiation Dosage
5
1979
122
0.190
Why?
Vascular Surgical Procedures
2
2000
67
0.190
Why?
Adult
15
1982
11572
0.190
Why?
Neoplasm Metastasis
2
2008
229
0.180
Why?
Antineoplastic Combined Chemotherapy Protocols
2
2003
436
0.180
Why?
Patient Selection
1
2011
223
0.180
Why?
Treatment Failure
2
2006
131
0.170
Why?
Thoracic Neoplasms
1
2009
20
0.170
Why?
Mathematics
2
1979
149
0.170
Why?
Liver Neoplasms
2
2006
155
0.170
Why?
Carotid Stenosis
2
1999
52
0.160
Why?
Female
20
1982
20222
0.160
Why?
Monte Carlo Method
4
1987
57
0.160
Why?
Tomography, X-Ray Computed
5
1987
785
0.160
Why?
Practice Guidelines as Topic
1
2010
319
0.150
Why?
Survival Analysis
2
2006
589
0.150
Why?
Glioma
1
2008
105
0.150
Why?
Muscle, Smooth, Vascular
2
2000
378
0.150
Why?
Paclitaxel
2
2003
59
0.140
Why?
Cisplatin
2
2003
93
0.140
Why?
Antineoplastic Protocols
1
2006
3
0.140
Why?
Hyperplasia
6
1998
95
0.140
Why?
Magnetic Resonance Imaging
4
1996
1019
0.140
Why?
Antineoplastic Agents
1
2011
628
0.140
Why?
Prochlorperazine
1
2005
11
0.130
Why?
Ondansetron
1
2005
11
0.130
Why?
Retrospective Studies
5
2006
2302
0.130
Why?
Biophysical Phenomena
4
1994
52
0.130
Why?
Radiotherapy, Conformal
2
2001
19
0.130
Why?
Biophysics
4
1994
61
0.130
Why?
Dose-Response Relationship, Radiation
8
1980
216
0.130
Why?
Antiemetics
1
2005
55
0.130
Why?
Decision Theory
3
1997
7
0.130
Why?
Vomiting
1
2005
116
0.120
Why?
Postoperative Care
1
2004
130
0.120
Why?
Film Dosimetry
3
1979
6
0.120
Why?
Dexamethasone
1
2005
188
0.120
Why?
Palladium
3
1996
15
0.120
Why?
Models, Structural
4
1987
53
0.120
Why?
Nausea
1
2005
155
0.120
Why?
Ifosfamide
1
2003
8
0.120
Why?
Catheterization
3
1998
124
0.120
Why?
Photogrammetry
1
2003
3
0.110
Why?
Carcinoma, Small Cell
1
2003
33
0.110
Why?
Radiation Protection
3
1987
23
0.110
Why?
Immobilization
1
2003
28
0.110
Why?
Peripheral Vascular Diseases
1
2002
27
0.110
Why?
Imaging, Three-Dimensional
1
2003
87
0.110
Why?
United States
4
1999
2847
0.100
Why?
Radiation Injuries
5
1984
131
0.100
Why?
Blood Vessel Prosthesis Implantation
1
2001
52
0.100
Why?
Image Enhancement
1
2003
148
0.100
Why?
Breast Neoplasms
2
2004
666
0.100
Why?
Radioisotopes
2
1996
51
0.100
Why?
Carotid Arteries
2
1998
106
0.100
Why?
Prostatic Diseases
1
2000
9
0.090
Why?
Cobalt Radioisotopes
2
1979
17
0.090
Why?
Computer Simulation
2
1999
304
0.090
Why?
Models, Biological
3
1990
1029
0.090
Why?
Models, Theoretical
4
1979
194
0.090
Why?
Calibration
1
1999
44
0.090
Why?
Intracranial Arteriovenous Malformations
1
1999
15
0.090
Why?
Models, Genetic
2
1996
162
0.090
Why?
Tantalum
1
1999
5
0.090
Why?
Alloys
1
1999
17
0.090
Why?
Vascular Diseases
1
2000
74
0.090
Why?
Nickel
1
1999
23
0.090
Why?
Survival Rate
3
2003
619
0.090
Why?
X-Rays
1
1999
28
0.090
Why?
Technology, Radiologic
1
1979
17
0.090
Why?
Graft Occlusion, Vascular
1
1999
25
0.080
Why?
Energy Transfer
2
1987
29
0.080
Why?
Ultrasonography, Interventional
1
1999
64
0.080
Why?
Angioplasty, Balloon, Coronary
1
1999
64
0.080
Why?
Titanium
1
1999
137
0.080
Why?
Coronary Artery Disease
1
1999
88
0.080
Why?
Kaplan-Meier Estimate
2
2008
207
0.080
Why?
Prognosis
4
1980
1078
0.080
Why?
Pilot Projects
3
1980
446
0.080
Why?
Platelet-Derived Growth Factor
1
1998
114
0.080
Why?
Coronary Disease
1
1999
257
0.070
Why?
Uterine Cervical Neoplasms
2
1987
125
0.070
Why?
Orbital Neoplasms
2
1985
26
0.070
Why?
Quality Assurance, Health Care
1
1998
130
0.070
Why?
Image Processing, Computer-Assisted
1
1998
262
0.070
Why?
Animals
9
1987
16416
0.070
Why?
Radiographic Image Enhancement
1
1996
59
0.070
Why?
Double-Blind Method
2
2005
996
0.070
Why?
Macrophages
1
1998
347
0.070
Why?
Iridium Radioisotopes
2
1989
14
0.070
Why?
Lymphoma
2
1985
163
0.060
Why?
Neoplasm Staging
2
2003
354
0.060
Why?
Radiography
1
1994
17
0.060
Why?
Phantoms, Imaging
3
1996
142
0.060
Why?
Plastics
3
1982
13
0.060
Why?
Multivariate Analysis
2
2004
548
0.060
Why?
Lung
3
1987
1148
0.060
Why?
Rectum
2
1987
56
0.060
Why?
Head and Neck Neoplasms
1
1994
84
0.060
Why?
Spinal Cord
1
1994
168
0.060
Why?
Bone Neoplasms
2
1980
208
0.060
Why?
Cell Survival
3
1987
559
0.050
Why?
Duodenum
1
1991
38
0.050
Why?
Connective Tissue
1
1991
45
0.050
Why?
Amifostine
1
1991
28
0.050
Why?
Quality Control
2
2000
71
0.050
Why?
Follow-Up Studies
2
1999
1889
0.050
Why?
Cholelithiasis
1
1991
18
0.050
Why?
Electrons
2
1982
12
0.050
Why?
Rats, Sprague-Dawley
3
1998
1036
0.050
Why?
Organizational Objectives
2
2001
27
0.050
Why?
Bone and Bones
2
1990
360
0.050
Why?
Neoplasm Recurrence, Local
3
1980
295
0.050
Why?
Biopsy
1
2011
384
0.050
Why?
Graphite
1
1990
2
0.050
Why?
Forecasting
2
2001
188
0.050
Why?
Combined Modality Therapy
2
1999
491
0.050
Why?
Intraoperative Period
2
1999
46
0.040
Why?
Bromodeoxyuridine
1
1989
68
0.040
Why?
Carotid Artery Injuries
2
1998
25
0.040
Why?
Equipment Design
1
1990
253
0.040
Why?
Salvage Therapy
1
2009
62
0.040
Why?
Disease-Free Survival
1
2009
204
0.040
Why?
Radiation-Sensitizing Agents
1
1989
74
0.040
Why?
Diagnosis, Differential
1
2011
889
0.040
Why?
Necrosis
3
1980
103
0.040
Why?
Radiochemistry
1
1987
4
0.040
Why?
Misonidazole
1
1987
9
0.040
Why?
Nitroimidazoles
1
1987
11
0.040
Why?
Urinary Bladder
1
1987
74
0.040
Why?
Comorbidity
1
2009
377
0.040
Why?
Time Factors
4
1980
3234
0.040
Why?
Remission Induction
1
2006
165
0.040
Why?
Disease Progression
1
2009
533
0.040
Why?
Recurrence
2
1998
697
0.040
Why?
Rats
3
1998
4389
0.040
Why?
Clinical Trials as Topic
2
1999
685
0.030
Why?
Serotonin Antagonists
1
2005
21
0.030
Why?
Carboplatin
1
2005
29
0.030
Why?
Doxorubicin
1
2005
105
0.030
Why?
Cyclophosphamide
1
2005
177
0.030
Why?
Pharyngeal Neoplasms
1
1984
7
0.030
Why?
Mouth Neoplasms
1
1984
34
0.030
Why?
Robotics
1
2005
77
0.030
Why?
Subtraction Technique
1
2003
12
0.030
Why?
Taxoids
1
2003
13
0.030
Why?
Prospective Studies
1
2008
1696
0.030
Why?
Motion
1
2003
43
0.030
Why?
Patient Satisfaction
1
2005
243
0.030
Why?
Anastomosis, Surgical
1
2002
70
0.030
Why?
Optics and Photonics
1
2003
43
0.030
Why?
Scattering, Radiation
2
1979
77
0.030
Why?
Posture
1
2003
112
0.030
Why?
Radiation Tolerance
1
2002
89
0.030
Why?
Evaluation Studies as Topic
2
1980
247
0.030
Why?
Sheep
1
2001
79
0.030
Why?
Respiration
1
2002
181
0.030
Why?
Polytetrafluoroethylene
1
2001
39
0.030
Why?
Vascular Patency
1
2001
67
0.030
Why?
Physics
1
2001
6
0.020
Why?
Physical Phenomena
1
2001
6
0.020
Why?
Movement
1
2002
168
0.020
Why?
Decision Making, Computer-Assisted
1
2000
13
0.020
Why?
Thermoluminescent Dosimetry
2
1989
4
0.020
Why?
Artificial Intelligence
1
2000
23
0.020
Why?
Interprofessional Relations
1
2001
78
0.020
Why?
Diagnostic Imaging
1
2001
86
0.020
Why?
Pubic Bone
1
1999
8
0.020
Why?
Soft Tissue Neoplasms
1
1980
46
0.020
Why?
Muscles
2
1990
347
0.020
Why?
Sarcoma
1
1980
64
0.020
Why?
Urethra
1
1999
50
0.020
Why?
Angioplasty, Balloon
1
2000
70
0.020
Why?
Arteriosclerosis
1
2000
97
0.020
Why?
Radiology
1
1999
29
0.020
Why?
Radiopharmaceuticals
1
1999
49
0.020
Why?
Cerebral Hemorrhage
1
1999
63
0.020
Why?
Child, Preschool
2
1991
2737
0.020
Why?
Computers
1
1979
83
0.020
Why?
Risk Factors
2
1991
2331
0.020
Why?
Quality of Life
1
2003
528
0.020
Why?
Cranial Irradiation
1
1998
13
0.020
Why?
Dose-Response Relationship, Drug
1
2001
1142
0.020
Why?
Prostate
1
1999
198
0.020
Why?
Disease Models, Animal
1
2001
974
0.020
Why?
Cell Adhesion
1
1998
270
0.020
Why?
Analysis of Variance
1
1999
749
0.020
Why?
Probability
1
1997
306
0.020
Why?
Child
2
1991
4342
0.020
Why?
Observer Variation
1
1996
146
0.020
Why?
Adolescent
2
1991
5044
0.020
Why?
Cell Line
2
1989
1623
0.020
Why?
Cell Division
1
1998
773
0.020
Why?
Cell Movement
1
1998
378
0.020
Why?
Mediastinum
1
1994
20
0.020
Why?
Photons
1
1994
19
0.020
Why?
Gases
2
1982
36
0.010
Why?
Urinary Diversion
1
1991
15
0.010
Why?
Parenteral Nutrition
1
1991
24
0.010
Why?
Brain
1
1999
1228
0.010
Why?
Cells, Cultured
2
1987
2589
0.010
Why?
Ileum
1
1991
51
0.010
Why?
Dogs
1
1991
492
0.010
Why?
Mathematical Computing
1
1990
11
0.010
Why?
Breast
1
1990
66
0.010
Why?
Surgical Procedures, Operative
1
1990
116
0.010
Why?
Interphase
1
1989
38
0.010
Why?
Etanidazole
1
1987
24
0.010
Why?
Methods
1
1987
225
0.010
Why?
Cricetulus
1
1987
97
0.010
Why?
Cricetinae
1
1987
393
0.010
Why?
Regression Analysis
1
1987
539
0.010
Why?
Infant
1
1991
2320
0.010
Why?
Oropharynx
1
1984
11
0.010
Why?
Neck
1
1984
35
0.010
Why?
Lymphatic Metastasis
1
1984
153
0.010
Why?
Gamma Rays
1
1982
69
0.010
Why?
Magnetics
1
1982
37
0.010
Why?
Osteoradionecrosis
1
1980
3
0.010
Why?
Gastrointestinal Diseases
1
1980
35
0.010
Why?
Mucous Membrane
1
1980
46
0.010
Why?
Central Nervous System Diseases
1
1980
59
0.010
Why?
Skin Diseases
1
1980
121
0.010
Why?

Visualizations


Schell's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department